You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Over the next year or so, the investigators plan to sequence the genomes of 3,000 patients with cancer, heart disease, diabetes, or neurological disorders.
After a recent consumer alert from the US Food and Drug Administration, the startup is modifying its sample collection process to only support physician in-person specimen collection.
The company's new KidneyCare test will include AlloSure for rejection, AlloMap for quiescence, and Cibiltech's AI algorithm for graft health information.
The acquisition of OTTR Complete Transplant Management will enable CareDx to integrate the EMRs of patients at transplant centers with longitudinal patient surveillance data.
The framework, called HEAL, could be used as an early screening test for AAA and as a personal health management tool. In addition, it may be applicable to other complex diseases.
The system relies on the use of scannable safety code cards containing patient data, along with a web portal and automated analysis tools that deliver customized diagnostic reports.
Irish rare disease research center FutureNeuro is partnering with software vendor Congenica to bring sequencing to the point of care for genetic epilepsies.
Siemens Healthineers has entered into an exclusive arrangement with health IT company Relaymed, which specializes in cloud-based point-of-care device connectivity services.
Founder Mark Harris and Gillian Hooker, VP of clinical development, explain why a more efficient Genetic Health Information Network is critical to the advancement of precision medicine.
The system allows oncologists to pick treatment regimens using NantHealth's decision support tool, and order them directly through Allscript's EHR system.